Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus

Pediatric Cardiology

Volumn 26, Issue 6, 2005, Pages 815-820

  Dimas, V V ^a   Taylor, M D ^a   Cunnyngham, C B ^b   Overholt, E D ^b   Bourne, D W A ^c   Stanely III, J R ^b   Sheikh, A ^b   Wolf, R ^c   Valentine, B ^c   Ward, K E ^b  

^a TEXAS CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

Author keywords

Fetus; Flecainide; Supraventricular tachycardia; Transplacental pharma kinectics

Indexed keywords

FLECAINIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BABOON; CONCENTRATION (PARAMETERS); CONFIDENCE INTERVAL; CORRELATION ANALYSIS; FEMALE; FETUS; FETUS BLOOD SAMPLING; GENERAL ANESTHESIA; GESTATIONAL AGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; LINEAR REGRESSION ANALYSIS; MOTHER FETUS RELATIONSHIP; NONHUMAN; PLACENTAL TRANSFER; PREGNANCY; STEADY STATE; SUPRAVENTRICULAR TACHYCARDIA; ULTRAVIOLET RADIATION; UMBILICAL CORD BLOOD;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; FEMALE; FETAL BLOOD; FETUS; FLECAINIDE; HYDROPS FETALIS; INFUSIONS, INTRAVENOUS; MATERNAL-FETAL EXCHANGE; PAPIO; PREGNANCY; TACHYCARDIA, SUPRAVENTRICULAR;

EID: 31144441929     PISSN: 01720643     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00246-005-0974-8     Document Type: Article

References (30)

1. Alp NJ, Bell JA, Shahi M (2000) Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation. Heart 84:37-40
2. Anderson DF, Phernetton TM, Rankin JH (1980) Prediction of fetal drug concentrations. Am J Obstet Gynecol 137:735-738
3. Barjot P, Hamel P, Calmelet P, Maragnes P, Herlicoviez M (1998) Flecainide against fetal supraventricular tachycardia complicated by hydrops fetalis. Acta Obstet Gynecol Scand 77:353-358
4. Cardiac Arrhythmia Suppression Trial Investigaters (1989) Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infraction. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. N Engl J Med 321:406-412
5. Flecainide acetate, AHFS Drug Information 98, pp. 1352-1360
6. Follath F, Ganzinger U, Schuetz E (1983) Reliability of antiarrhythmic drug plasma concentration monitoring. Clin Pharmacokinet 8:63-82
7. Garland M (2003) Pharmacology of drug transfer across the placenta. Obstet Gynecol Clin North Am 25:21-42
8. Garland M, Szeto HH, Salha DS, et al. (1998) Implications of the kinetics of zidovudine in the pregnant baboon following oral administration. J Acquir Immune Defic Syndr 19:433-440
9. Gillet JY, Bongain A, Abrar D, Garraffo R, Lapalus P (1990) Preliminary study on the transport of AZT (Retrovirzidovudine) through the placenta. J Gynecol Obstet Biol Reprod 19:177-180
10. Joglar JA, Page RL (2001) Antiarrhythmic drugs in pregnancy. Curr Opin Cardiol 16:40-45
11. Khositseth A, Ramin KD, O'Leary PW, Porter CJ (2003) The role of amiodarone in the treatment of fetal supraventricular tachyarrhythmias and hydrops fetalis. Pediatr Cardiol 24:454-456
12. Kofinas AD, Simon NV, Sagel H, et al. (1991) Treatment of supraventricular tachycardia with flecainide after digoxin failure. Am J Obstet Gynecol 165:630-631
13. O'Sullivan MJ, Boyer PH, Scott GB, et al. (1993) The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: phase I acquired immunodeficiency syndrome clinical trials group study (protocol 082). Am J Obstet Gynecol 168:1510-1506
14. Oudijk MA, Ruskamp JM, Ambachtsheer BE, et al. (2002) Drug treatment of fetal tachycardias. Paediatr Drugs 4:49-63
15. Oudijk MA, Visser GH, Meijboom EJ (2004) Fetal tachyarrhythmia - part II: treatment. Indian Pacing Electrophysiol J 4:185-194
16. Palmer CM, Norris MC (1990) Placental transfer of flecainide. Am J Dis Child 144:144
17. Perry JC, Ayres NA, Carpenter RJ (1991) Fetal supraventricular tachycardia treated with flecainide acetate. J Pediatr 118:303-305
18. Schmolling J, Jung S, Reinsberg J, Schlebusch H (1996) Digoxin transfer across the isolated placenta is influenced by maternal and fetal albumin concentrations. Reprod Fertil Dev 8:969-974
19. Shearer MH, Lucas AH, Anderson PW, et al. (1997) The baboon as a nonhuman primate model for assessing the effects of maternal immunization with haemophilus influenzae type b polysaccharide vaccines. Infect Immun 65:3267-3270
20. Simpson JM, Sharland GK (1999) Fetal tachycardias: management and outcome of 127 consecutive cases. Obstet Gynecol Surv 54:91-92
21. Tambocor, prescribing information, 3M Pharmaceuticals
22. Till JA, Shinebourne EA, Rowland E, et al. (1989) Paediatric use of flecainide in supraventricular tachycardia: clinical efficacy and pharmacokinetics. Br Heart J 62:133-139
23. Tomek V, Marek J, Spalova I, et al. (2002) Intraumbilical therapy of fetal supraventricular tachycardia. Ceska Gynekol 67:380-383
24. van Engelen AD, Weitjens O, Brenner JL, et al. (1994) Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 24:1371-1375
25. Van Gelder-Hasker MR, de Jong CLD, de Vries JLP, Van Geijn HP (1995) The effect of flecainide acetate on fetal heart rate variability: a case report. Obstet Gynecol 86:667-669
26. Vanbesien J, Casteels A, Bougatef A, et al. (2001) Transient fetal hypothyroidism due to direct fetal administration of amiodarone for drug resistant fetal tachycardia. Am J Perinatol 18:113-116
27. Vanderhal AL, Cocjin J, Santulli TV Jr, Carlson DE, Rosenthal P (1995) Conjugated hyperbilirubinemia in a newborn infant after maternal (transplacental) treatment with flecainide acetate for fetal tachycardia and fetal hydrops. J Pediatr 126:988-990
28. Ward RM (1993) Drug therapy of the fetus. J Clin Pharmacol 33:780-789
29. Wren C, Hunter S (1988) Maternal administration of flecainide to terminate and suppress fetal tachycardia. Br Med J 296:249
30. Younis JS, Granat M (1987) Insufficient transplacental digoxin transfer in severe hydrops fetalis. Am J Obstet Gynecol 157:1268-1269